Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

New market introduction for antiestrogen

Nov. 28, 1996

Another European market introduction for Epivir

Nov. 28, 1996

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Canadian scientists identify new target for respiratory drugs

Nov. 28, 1996

Intracardiac illuminator offered for licensing

Nov. 28, 1996

Novel vaccine delivery system available for licensing

Nov. 28, 1996

Licenses available for lung function monitor

Nov. 28, 1996

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Nov. 28, 1996

Cancer diagnostic based on p53 offered for licensing

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...